Unveiling 5 Analyst Insights On Healthcare Realty Trust
Portfolio Pulse from Benzinga Insights
In the last three months, 5 analysts have published ratings on Healthcare Realty Trust (NYSE:HR), with a range of perspectives from bullish to bearish. The average 12-month price target has decreased from $16.40 to $16.00. Analysts have adjusted their ratings and price targets in response to recent developments, reflecting a cautious outlook on the company's financial performance.
May 30, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have provided mixed ratings on Healthcare Realty Trust, with the average 12-month price target decreasing from $16.40 to $16.00. The company's financial performance shows challenges, including a decline in revenue growth and below-average net margins.
The decrease in the average 12-month price target and the mixed ratings from analysts indicate a cautious outlook on Healthcare Realty Trust. The company's financial performance, including declining revenue growth and below-average net margins, suggests potential challenges ahead, likely leading to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100